NDC 70518-4359-04 - HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4359
- Requested NDC
- 70518-4359-04
- Package NDCs from labels
- 70518-4359-0, 70518-4359-1, 70518-4359-2, 70518-4359-3, 70518-4359-4, 70518-4359-04
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS, USP Rx only | REMEDYREPACK INC. | 2026-10-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4359-0 | HYDROCHLOROTHIAZIDE | 15 in 1 BOTTLE, PLASTIC | TABLET | 15 | 3 | |
| 70518-4359-1 | HYDROCHLOROTHIAZIDE | 30 in 1 BLISTER PACK | TABLET | 30 | 3 | |
| 70518-4359-2 | HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diovan HCT | VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | d76a0419-05ee-437e-884c-65807aea9569 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 9fe534cd-cf5f-64b4-e053-2995a90a926e | 2026-02-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 5ec290f4-bf21-4c5b-a576-8eb2bd6bd379 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals Inc | 911a18c1-120a-46b3-b7a8-25eb37843473 | 2026-02-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Prasco Laboratories | 9d350fa2-d568-4970-a7a5-d128ff5d0a2f | 2026-02-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 96838fd0-ad87-4b45-b2c0-efdd1d2f3d1e | 2026-02-06 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 088cb67f-3eaa-4e78-9fbe-ad2d6b7c5707 | 2026-02-06 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f1f99065-04d2-48ac-b25d-9595237c869c | 2026-02-06 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | af46984c-cb58-4886-baa2-0ee075242c27 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | bb362b67-4a14-4491-9e12-0f7d5c7a65bc | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | de2d4628-08b3-4e31-aacc-ed85897f52e3 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 89f525cb-fa15-4407-8cbf-14e7f6bf9055 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 0dbc5ebb-99ab-428d-b9b3-cd7a68dd948a | 2026-02-04 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | de815d64-b8d4-46a8-95b8-c230abe7f767 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 83f4acc1-697a-4770-b554-1b9a8fb5de74 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e842fa14-b18e-4463-9bf1-a1c8700fe33c | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 686a5743-adc9-4729-9dbf-5cbc2c23897a | 2026-01-19 | Warnings, Adverse reactions | ANDA085182 429503 0J48LPH2TH |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | AvKARE | 017bc6a3-5b3d-2381-e063-6394a90abece | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Coupler LLC | 44fd38d2-cb8b-d0e8-e063-6294a90a994e | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 05ba1369-6484-75d4-e063-6294a90a63e4 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.